Disease

Congenital Heart Disease Studies

4 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 2, 2026 · JOURNAL ARTICLE

Contemporary Evaluation and Management Strategies for Tricuspid Regurgitation

Critical Pathways in Cardiology a Journal of Evidence-based Medicine

A comprehensive narrative review synthesizing current literature on TR evaluation and management strategies, presenting expert consensus on classification, imaging, risk stratification, and therapeutic options without new primary data.

Expert GuidanceMarzieh Mirtajaddini Nasim Naderi Cardiac Valve Diseases and Treatments

Study details

DesignNarrative review

AUG 28, 2026 · JOURNAL ARTICLE

Structural Heart Interventions in Women with Congenital Heart Disease

Current Cardiology Reports

A narrative review synthesizing current evidence on transcatheter interventions and sex-specific management considerations in women with congenital heart disease, without new empirical data or a systematic evidence synthesis.

Expert GuidanceShiva Barforoshi Pei-Ni Jone Jennifer Co-Vu

AUG 6, 2026 · JOURNAL ARTICLE

New ESC/EACTS guidelines for the management of aortic valve disease: key takeaways and implications of long-term TAVR results based on recent explant and redo-TAVR registry outcomes

Journal of Cardiothoracic Surgery

A narrative review synthesizing guideline updates and registry evidence on TAVR durability and reintervention; informs clinical decision-making but lacks original comparative effectiveness data.

Expert GuidanceAortic Disease and Treatment Approaches Cardiac Valve Diseases and Treatments Congenital Heart Disease Studies

Reported

Reintervention rate at 8 years0.3–1.7%

30-day mortality after redo-TAVR1.5–6.2%

30-day mortality after explantati…11.9–13.6%

JUN 29, 2026 · JOURNAL ARTICLE

A bibliometric analysis of medication studies in congenital heart disease

International Journal of Cardiology Congenital Heart Disease

A bibliometric analysis characterizing the landscape of medication studies in congenital heart disease, documenting low RCT prevalence (29.4%) and publication trends, but offering no direct clinical efficacy data or intervention comparisons.

PreliminaryHugo Veldtman Gruschen Veldtman Sarah Brock

Reported

Total studies included160

Total participants across all stu…59,208

Participants with sex reported20,092